Chronic d-Fenfluramine treatment reduces fat intake independent of macronutrient preference

Pharmacology Biochemistry and Behavior

Volumn 60, Issue 1, 1998, Pages 105-114

  Smith, Brenda K ^a   York, David A ^a   Bray, George A ^a  

^a Obesity   (United States)

Author keywords

Carbohydrate; Dexenfluramine; Fat; Food intake; Macronutrient selection

Indexed keywords

DEXFENFLURAMINE;

ANIMAL EXPERIMENT; ARTICLE; CALORIC INTAKE; CARBOHYDRATE INTAKE; CONTROLLED STUDY; FAT INTAKE; FOOD INTAKE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTAKE; WEIGHT GAIN;

ANIMALS; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; EATING; FENFLURAMINE; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGONISTS;

ANIMALIA;

EID: 0032078052     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00549-2     Document Type: Article

References (48)

1. Abdulbasit I. I. A., Plested C. P., Rolland Y., Brindley D. N. Decreased incorporation of glucose into lipids and increased lactate production by adipose tissue after long-term treatment of rats with D-fenfluramine. Biochem. Pharmacol. 38:1989;3661-3667.
2. Blundell J. E., Hill A. J. Do serotoninergic drugs decrease energy intake by reducing fat or carbohydrate intake? Effect of d-fenfluramine with supplemented weight-increasing diets. Pharmacol. Biochem. Behav. 31:1989;773-778.
3. Blundell J. E., Lawton C. L. Serotonin and dietary fat intake. Effects of dexfenfluramine Metabolism. 44(Suppl. 2):1995;33-37.
4. Boschmann M., Frenz U., Murphy C. M., Noack R. Changes in energy metabolism and metabolite patterns of obese rats after application of dexfenfluramine. Pharmacol. Biochem. Behav. 53:1996;549-558.
5. Breum L., Moller S.-E., Andersen T., Astrup A. Long-term effect of dexfenfluramine on amino acid profiles and food selection in obese patients during weight loss. Int. J. Obes. 20:1996;147-153.
6. Brindley D. N., Pritchard P. H., Sturton R. G., Birmingham A. T. A mechanism by which fenfluramine and benfluorex could inhibit the synthesis of triacylglycerols [proceedings]. Br. J. Pharmacol. 64(3):1978;377P-378P.
7. Carlton J., Rowland N. Effects of initial body weight on anorexia and tolerance to fenfluramine in rats. Pharmacol. Biochem. Behav. 23:1985;551-554.
8. Carlton J., Rowland N. E. Long term actions of d-fenfluramine in two rat models of obesity. Int. J. Obes. 13:1989;825-847.
9. Comai K., Triscari J., Sullivan A. C. Comparative effects of amphetamine and fenfluramine on lipid biosynthesis and absorption in the rat. Biochem. Pharmacol. 27:1994;1987-1994.
10. Curtis-Prior P. B., Prouteau M. Qualitative and quantitative effects of fenfluramine and tiflorex on food consumption in trained rats offered dietary choices. Int. J. Obes. 7:1983;575-581.
11. Fisler J. S., Underberger S. J., York D. A., Bray G. A. d-Fenfluramine in a rat model of dietary fat-induced obesity. Pharmacol. Biochem. Behav. 45:1993;487-493.
12. Fletcher P. J., Paterson I. A. A comparison of the effects of tryptamine and 5-hydroxytryptamine on feeding following injection into the paraventricular nucleus of the hypothalamus. Pharmacol. Biochem. Behav. 32:1989;907-911.
13. Gibson E. L., Kennedy A. J., Curzon G. d-Fenfluramine- and d-norfenfluramine-induced hypophagia. Differential mechanisms and involvement of postsynaptic 5-HT receptors Eur. J. Pharmacol. 242:1993;83-90.
14. Glowa J. R., Barrett J. E., Russell J., Gold P. W. Effects of corticotropin releasing hormone on appetitive behaviors. Peptides. 13:1992;609-621.
15. Goodall E. M., Cowen P. J., Franklin M., Silverstone T. Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers. Psychopharmacology (Berlin). 112:1993;461-466.
16. Gray T. S., Javed A., Kamradt M., Bartholomew D., Van de Kar L. D. Dexfenfluramine elevates c-fos expression in hypothalamic CRF and oxytocin neurons via a serotonergic mechanism. Soc. Neurosci. Abstr. 22:1996;477.
17. Hirsch J. A., Goldberg S., Wurtman R. J. Effect of (+)- or (-)-enantiomers of fenfluramine or norfenfluramine on nutrient selection by rats. J. Pharm. Pharmacol. 34:1982;18-21.
18. Holmes M. C., Di Renzo G., Beckford U., Gillham B., Jones M. T. Role of serotonin in the control of secretion of corticotrophin releasing factor. J. Endocrinol. 93:1982;151-160.
19. Kanarek R. B., Dushkin H. Peripheral serotonin administration selectively reduces fat intake in rats. Pharmacol. Biochem. Behav. 31:1988;113-122.
20. Kanarek R. B., Glick A. L., Marks-Kaufman R. Dietary influences on the acute effects of anorectic drugs. Physiol. Behav. 49:1991;149-152.
21. Kim S. H., Wurtman R. J. Selective effects of CGS 10686B, dl-fenfluramine or fluoxetine on nutrient selection. Physiol. Behav. 42:1988;319-322.
22. Laflamme N., Bovetto S., Richard D., Rivest S. Effect of dexfenfluramine on the transcriptional activation of CRF and its type 1 receptor within the paraventricular nucleus of the rat hypothalamus. Br. J. Pharmacol. 117:1996;1021-1034.
23. Lafreniere F., Lambert J., Rasio E., Serri O. Effects of dexfenfluramine treatment on body weight and postprandial thermogenesis in obese subjects. Int. J. Obes. 17:1993;25-30.
24. Le Feuvre R. A., Aisenthal L., Rothwell N. J. Involvement of corticotrophin releasing factor (CRF) in the thermogenic and anorexic actions of serotonin (5-HT) and related compounds. Brain Res. 555:1991;245-250.
25. Lin L., York D., Bray G. Acute effects of intracerebroventricular corticotropin releasing hormone (CRH) on macronutrient selection. Int. J. Obes. 16(Suppl. 1):1992;52.
26. Luo S. Q., Li E. T. Food intake and selection pattern of rats treated with dexfenfluramine, fluoxetine and RU 24969. Brain Res. Bull. 24:1990;729-733.
27. Luo S., Li E. T. S. Effects of repeated administration of serotonergic agonists on diet selection and body weight in rats. Pharmacol. Biochem. Behav. 38:1991;495-500.
28. Max J. P., Thystere P., Chapleur-Chateau M., Burlet A., Nicolas J. P., Burlet C. Hypothalamic neuropeptides could mediate the anorectic effects of fenfluramine. Neuroreport. 5:1994;1925-1928.
29. Miller G. D., Dimond A. G., Stern J. S. Exercise reduces fat selection in female Sprague-Dawley rats. Med. Sci. Sports Exerc. 26:1994;1466-1472.
30. Oluyomi A. O., Gibson E. L., Barnfield A. M. C., Curzon G. d-Fenfluramine and d-norfenfluramine hypophagias do not require increased hypothalamic 5-hydroxytryptamine release. Eur. J. Pharmacol. 264:1994;111-115.
31. Orthen-Gambill N., Kanarek R. B. Differential effects of amphetamine and fenfluramine on dietary self-selection in rats. Pharmacol. Biochem. Behav. 16:1982;303-309.
32. Overmann S. R. Dietary self-selection by animals. Psychol. Bull. 83:1976;218-235.
33. Raiteri M., Bonanno G., Vallebuona F. In vitro and in vivo effects of d-fenfluramine. No apparent relation between 5-hydroxytryptamine release and hypophagia J. Pharmacol. Exp. Ther. 273:1995;643-649.
34. Rowland N. E. Effect of continuous infusions of dexfenfluramine on food intake, body weight and brain amines in rats. Life Sci. 39:1986;2581-2586.
35. Rowland N. E. Dexfenfluramine. Effects on food intake in various animal models Clin. Neuropharmacol. 11:1988;S33-S50.
36. Rowland N. E., Carlton J. Neurobiology of an anorectic drug. Fenfluramine Prog. Neurobiol. 27:1986;13-62.
37. Schwartz D., Hernandez L., Hoebel B. G. Fenfluramine administered systemically or locally increases extracellular serotonin in the lateral hypothalamus as measured by microdialysis. Brain Res. 482:1989;261-270.
38. Shor-Posner G., Brennan G., Ian C., Jasaitis R., Madhu K., Leibowitz S. F. Meal patterns of macronutrient intake in rats with particular dietary preferences. Am. J. Physiol. 266:1994;R1395-R1402.
39. Shor-Posner G., Grinker J. A., Marinescu C., Brown O., Leibowitz S. F. Hypothalamic serotonin in the control of meal patterns and macronutrient selection. Brain Res. Bull. 17:1986;663-671.
40. Shor-Posner G., Ian C., Brennan G., Cohn T., Moy H., Ning A., Leibowitz S. F. Self-selecting albino rats exhibit differential preferences for pure macronutrient diets. Characterization of three subpopulations Physiol. Behav. 50:1991;1187-1195.
41. Smith B. K., York D. A., Bray G. A. Effects of dietary preference and galanin administration in the paraventricular or amygdaloid nucleus on diet self-selection. Brain Res. Bull. 39:1996;149-154.
42. Smith B. K., York D. A., Bray G. A. Further evidence that the serotoninergic system regulates fat intake. FASEB J. 11:1997;A357.
43. Smith B. K., York D. A., Bray G. A. Differential effects of baseline macronutrient preferences on macronutrient selection after galanin, NPY, and an overnight fast. Peptides. 18:1997;207-211.
44. Souquet A., Rowland N. E. Effect of chronic administration of dexfenfluramine on stress- and palatability-induced food intake in rats. Physiol. Behav. 46:1989;145-149.
45. Weiss G. F., Rogacki N., Fueg A., Buchen D., Leibowitz S. F. Impact of hypothalamic d-norfenfluramine and peripheral d-fenfluramine injection on macronutrient intake in the rat. Brain Res. Bull. 25:1990;849-859.
46. Welch C. C., Grace M. K., Billington C. J., Levine A. S. Preference and diet type affect macronutrient selection after morphine, NPY, norepinephrine, and deprivation. Am. J. Physiol. 266:1994;R426-R433.
47. Wurtman J. J., Wurtman R. J. Fenfluramine and fluoxetine spare protein consumption while suppressing caloric intake by rats. Science. 198:1977;1178-1180.
48. Wurtman J. J., Wurtman R. J., Mark S., Tsay R., Gilbert W., Growdon J. d-Fenfluramine selectively suppresses carbohydrates snacking by obese subjects. Int. J. Eat. Disord. 4:1985;89-99.